These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 35737381)

  • 1. Multilevel Factors Associated With Time to Biopsy After Abnormal Screening Mammography Results by Race and Ethnicity.
    Lawson MB; Bissell MCS; Miglioretti DL; Eavey J; Chapman CH; Mandelblatt JS; Onega T; Henderson LM; Rauscher GH; Kerlikowske K; Sprague BL; Bowles EJA; Gard CC; Parsian S; Lee CI
    JAMA Oncol; 2022 Aug; 8(8):1115-1126. PubMed ID: 35737381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Access to and Use of Digital Breast Tomosynthesis Screening by Women's Race/Ethnicity and Socioeconomic Status.
    Lee CI; Zhu W; Onega T; Henderson LM; Kerlikowske K; Sprague BL; Rauscher GH; O'Meara ES; Tosteson ANA; Haas JS; diFlorio-Alexander R; Kaplan C; Miglioretti DL
    JAMA Netw Open; 2021 Feb; 4(2):e2037546. PubMed ID: 33606032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of a Risk-Based Approach for Triaging Mammography Examinations During Periods of Reduced Capacity.
    Miglioretti DL; Bissell MCS; Kerlikowske K; Buist DSM; Cummings SR; Henderson LM; Onega T; O'Meara ES; Rauscher GH; Sprague BL; Tosteson ANA; Wernli KJ; Lee JM; Lee CI
    JAMA Netw Open; 2021 Mar; 4(3):e211974. PubMed ID: 33764423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Racial Disparities and Strategies for Improving Equity in Diagnostic Follow-Up for Abnormal Screening Mammograms.
    Manik R; Grady CB; Ginzberg SP; Edmonds CE; Conant EF; Hubbard RA; Fayanju OM
    JCO Oncol Pract; 2024 Oct; 20(10):1367-1375. PubMed ID: 38900977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic Mammography Performance across Racial and Ethnic Groups in a National Network of Community-Based Breast Imaging Facilities.
    Nyante SJ; Abraham L; Aiello Bowles EJ; Lee CI; Kerlikowske K; Miglioretti DL; Sprague BL; Henderson LM;
    Cancer Epidemiol Biomarkers Prev; 2022 Jul; 31(7):1324-1333. PubMed ID: 35712862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are there racial/ethnic disparities among women younger than 40 undergoing mammography?
    Kapp JM; Walker R; Haneuse S; Buist DS; Yankaskas BC
    Breast Cancer Res Treat; 2010 Nov; 124(1):213-22. PubMed ID: 20204501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate and Timeliness of Diagnostic Evaluation and Biopsy After Recall From Screening Mammography in the National Mammography Database.
    Oluyemi ET; Grimm LJ; Goldman L; Burleson J; Simanowith M; Yao K; Rosenberg RD
    J Am Coll Radiol; 2024 Mar; 21(3):427-438. PubMed ID: 37722468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of Screening Ultrasonography as an Adjunct to Screening Mammography in Women Across the Spectrum of Breast Cancer Risk.
    Lee JM; Arao RF; Sprague BL; Kerlikowske K; Lehman CD; Smith RA; Henderson LM; Rauscher GH; Miglioretti DL
    JAMA Intern Med; 2019 May; 179(5):658-667. PubMed ID: 30882843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delays in Follow-up Care for Abnormal Mammograms in Mobile Mammography Versus Fixed-Clinic Patients.
    Vang SS; Dunn A; Margolies LR; Jandorf L
    J Gen Intern Med; 2022 May; 37(7):1619-1625. PubMed ID: 35212876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of California's Breast Density Notification Legislation on Breast Cancer Screening.
    Chau SL; Alabaster A; Luikart K; Brenman LM; Habel LA
    J Prim Care Community Health; 2017 Apr; 8(2):55-62. PubMed ID: 27799412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in abnormal mammogram follow-up time for Asian women compared with non-Hispanic white women and between Asian ethnic groups.
    Nguyen KH; Pasick RJ; Stewart SL; Kerlikowske K; Karliner LS
    Cancer; 2017 Sep; 123(18):3468-3475. PubMed ID: 28603859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening mammographic performance by race and age in the National Mammography Database: 29,479,665 screening mammograms from 13,181,241 women.
    Lee CS; Goldman L; Grimm LJ; Liu IX; Simanowith M; Rosenberg R; Zuley M; Moy L
    Breast Cancer Res Treat; 2024 Feb; 203(3):599-612. PubMed ID: 37897646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparities in Same-Day Diagnostic Imaging in Breast Cancer Screening: Impact of an Immediate-Read Screening Mammography Program Implemented During the COVID-19 Pandemic.
    Dontchos BN; Achibiri J; Mercaldo SF; Wang GX; Lamb LR; Miles RC; Narayan AK; Lehman CD
    AJR Am J Roentgenol; 2022 Feb; 218(2):270-278. PubMed ID: 34494449
    [No Abstract]   [Full Text] [Related]  

  • 15. Cumulative 6-Year Risk of Screen-Detected Ductal Carcinoma In Situ by Screening Frequency.
    Sprague BL; Chen S; Miglioretti DL; Gard CC; Tice JA; Hubbard RA; Aiello Bowles EJ; Kaufman PA; Kerlikowske K
    JAMA Netw Open; 2023 Feb; 6(2):e230166. PubMed ID: 36808238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mammography facilities serving vulnerable women have longer follow-up times.
    Karliner LS; Kaplan C; Livaudais-Toman J; Kerlikowske K
    Health Serv Res; 2019 Feb; 54 Suppl 1(Suppl 1):226-233. PubMed ID: 30394526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of previous benign breast biopsy on the interpretive performance of subsequent screening mammography.
    Taplin SH; Abraham L; Geller BM; Yankaskas BC; Buist DS; Smith-Bindman R; Lehman C; Weaver D; Carney PA; Barlow WE
    J Natl Cancer Inst; 2010 Jul; 102(14):1040-51. PubMed ID: 20601590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Time to Diagnostic Evaluation After Mammographic Screening in an Urban Setting.
    Oppong BA; Dash C; Coleman T; Torres T; Adams-Campbell LL
    J Womens Health (Larchmt); 2016 Dec; 25(12):1225-1230. PubMed ID: 27182625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population Attributable Risk of Advanced-Stage Breast Cancer by Race and Ethnicity.
    Kerlikowske K; Chen S; Bissell MCS; Lee CI; Tice JA; Sprague BL; Miglioretti DL
    JAMA Oncol; 2024 Feb; 10(2):167-175. PubMed ID: 38060241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.